Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 22.59M P/E - EPS this Y -11.00% Ern Qtrly Grth -
Income -49.25M Forward P/E -0.52 EPS next Y 27.10% 50D Avg Chg -10.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 148.00%
Dividend N/A Price/Book 0.85 EPS next 5Y - 52W High Chg -46.00%
Recommedations 1.80 Quick Ratio 1.43 Shares Outstanding 7.82M 52W Low Chg 889.00%
Insider Own 2.67% ROA -81.22% Shares Float 6.73M Beta 1.50
Inst Own 27.63% ROE -180.44% Shares Shorted/Prior 30.47K/30.43K Price 3.56
Gross Margin - Profit Margin - Avg. Volume 157,688 Target Price 15.83
Oper. Margin - Earnings Date Nov 9 Volume 66,617 Change 8.21%
About Aptose Biosciences, Inc.

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and Tuspetinib, an oral potent myeloid kinase inhibitor that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, an orally administered, and potent dual lymphoid and myeloid kinome inhibitor that is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS. It has agreements with CrystalGenomics, Inc. and Hanmi Pharmaceutical Co. Ltd. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

Aptose Biosciences, Inc. News
11/10/23 Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcript
11/09/23 Aptose Reports Results for the Third Quarter 2023
11/02/23 Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
10/30/23 Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
10/26/23 Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023
10/23/23 Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
10/16/23 Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
09/18/23 Aptose to Present at the Cantor Global Healthcare Conference
09/08/23 Companies Like Aptose Biosciences (TSE:APS) Could Be Quite Risky
09/06/23 Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
08/24/23 Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/10/23 Aptose Reports Results for the Second Quarter 2023
07/27/23 Aptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023
06/26/23 Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
06/10/23 Aptose Presents Highlights from Clinical Update
06/05/23 Aptose Biosciences Provides Update on Reverse Stock Split
05/31/23 Aptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023
05/25/23 Aptose Enters into $25 Million Committed Equity Facility
05/23/23 Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
05/21/23 3 Stocks With 1,000% Upside Potential
APTO Chatroom

User Image StockAutomatePro Posted - 16 hours ago

$APTO The chart is predicting a rough patch for the stock. We alerted the SELL signal at $2.84 and we were able to close this one with profit at $2.22 💖

User Image tickeron Posted - 5 days ago

A.I.dvisor is predicting $APTO is about to fall. View odds of downtrend. https://srnk.us/go/4922882

User Image St0ckt0k101 Posted - 6 days ago

$APTO $2.00! Very bearish here🗑️💀💯

User Image tickeron Posted - 1 week ago

Wow this is a big change! $APTO MACD Histogram turned negative on November 20, 2023. View odds of downtrend. https://srnk.us/go/4921298

User Image tickeron Posted - 1 week ago

Wow this is a big change! $APTO MACD Histogram turned negative on November 15, 2023. View odds of downtrend. https://srnk.us/go/4916737

User Image EarningsCal Posted - 2 weeks ago

Upcoming Earnings Report: $APTO Aptose Biosciences will be reporting on 11/09/2023 at 4:02PM | Are you looking for a positive or negative earnings outcome?

User Image yaniv406 Posted - 2 weeks ago

$APTO This is a company that steals money, I've always said it's fraud and there is no organization in the US that deals with such companies and throws them all in jail.

User Image tickeron Posted - 2 weeks ago

How does this make you feel? $APTO entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4912144

User Image perchedcats Posted - 2 weeks ago

$APTO wow 30M market cap

User Image STCKPRO Posted - 2 weeks ago

$APTO NEW ARTICLE : Promising Financial Performance and Clinical Developments Bolster Aptose Biosciences’ Buy Rating: An Analysis by Joseph Pantginis https://www.stck.pro/news/APTO/67056673/

User Image Last10K Posted - 2 weeks ago

$APTO just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/APTO/0001171843-23-006958.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=APTO

User Image cctranscripts Posted - 2 weeks ago

Check out explanations offered up on the subject of $APTO earnings transcript https://conferencecalltranscripts.com/summary/?id=534478&pr=true

User Image Last10K Posted - 2 weeks ago

$APTO just filed a 10-Q Quarterly Report with 5 financial statements and 45 disclosures: https://last10k.com/sec-filings/apto/0000950170-23-062207.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=apto

User Image cctranscripts Posted - 2 weeks ago

Aptose Biosciences Just Filed Its Quarterly Report: Loss per share is ca... https://www.conferencecalltranscripts.org/summary/?id=12694044 $APTO

User Image EarningsInsider Posted - 2 weeks ago

Aptose Biosciences Inc. Files SEC Form 10-Q $APTO https://www.marketbeat.com/stocks/NASDAQ/APTO/sec-filings/

User Image cctranscripts Posted - 2 weeks ago

Aptose Reports Results For The Third Quarter 2023 Tuspetinib (TUS) Targets Venetoclax (VEN) Res https://www.conferencecalltranscripts.org/summary/?id=12693289 $APTO

User Image epsguid Posted - 2 weeks ago

$APTO reported a loss of $1.76, consensus was ($2.16) via @eWhispers #epsbeat http://eps.sh/d/apto

User Image Stock_Titan Posted - 2 weeks ago

$APTO Aptose Reports Results for the Third Quarter 2023 https://www.stocktitan.net/news/APTO/aptose-reports-results-for-the-third-quarter-1z5g2sggn3vp.html

User Image EarningsCal Posted - 3 weeks ago

Upcoming Earnings Report: $APTO Aptose Biosciences will be reporting on 11/09/2023 at 4:02PM | Are you looking for a positive or negative earnings outcome?

User Image perchedcats Posted - 3 weeks ago

@spyderman360 1 months away. Make or break for $APTO

User Image SkiDean Posted - 3 weeks ago

$APTO are we greedy

User Image Last10K Posted - 3 weeks ago

$APTO just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/APTO/0001171843-23-006639.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=APTO

User Image spyderman360 Posted - 3 weeks ago

$APTO https://www.aptose.com/news-media/press-releases/detail/280/aptose-tuspetinib-clinical-data-selected-for-oral

User Image cctranscripts Posted - 3 weeks ago

Aptose Tuspetinib Clinical Data Selected For Oral Presentation At The 2023 Ash Annual Meeting https://www.conferencecalltranscripts.org/summary/?id=12667200 $APTO

User Image Stock_Titan Posted - 3 weeks ago

$APTO Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting https://www.stocktitan.net/news/APTO/aptose-tuspetinib-clinical-data-selected-for-oral-presentation-at-33sgkoufkdbu.html

User Image St0ckt0k101 Posted - 10/31/23

$APTO I totally agree 👇🏾👇🏾💯📉

User Image tickeron Posted - 10/31/23

What do you think of this? $APTO entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4902622

User Image STCKPRO Posted - 10/31/23

$APTO NEW ARTICLE : Oppenheimer Reaffirms Their Buy Rating on Aptose Biosciences (APTO) https://www.stck.pro/news/APTO/66158010/

User Image STCKPRO Posted - 10/31/23

$APTO NEW ARTICLE : Promising Trial Data and Expansion Plans Boost Confidence in Aptose Biosciences: An Analysis of John Newman’s Buy Rating https://www.stck.pro/news/APTO/66153553/

User Image HoHoHoHum Posted - 10/30/23

$VBIV a lot of given up for dead stocks are coming back. wondering if this is the bio bottom. $BNGO $APTO some of the others

Analyst Ratings
Piper Sandler Overweight Aug 11, 23
RBC Capital Outperform Aug 11, 23
HC Wainwright & Co. Buy Aug 11, 23
Oppenheimer Outperform Aug 11, 23
Cantor Fitzgerald Overweight Jun 12, 23
HC Wainwright & Co. Buy Jun 12, 23
Oppenheimer Outperform Jun 12, 23
Piper Sandler Overweight Jun 7, 23
RBC Capital Outperform Jun 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Seizinger Bernd R. Director Director Sep 22 Buy 3.14 17,000 53,380 17,000 09/25/23
Payne Fletcher SR VP & Chief Fin. O.. SR VP & Chief Fin. Officer Sep 19 Buy 0.6775 10,000 6,775 10,000 09/21/22
- - - Aug 05 Buy 2.65 57,199 151,577 8,948,275 08/05/21
- - - Aug 05 Sell 2.62 60,000 157,200 8,888,275 08/05/21
Whitehead Warren Director Director Dec 28 Option 2.01 20,000 40,200 60,000 12/28/20
Whitehead Warren Director Director Dec 28 Sell 4.06 20,000 81,200 40,000 12/28/20